Faculty of Health Science, School of Physical Therapy, Western University, London, Canada.
Collaborative Program in Musculoskeletal Health Research, Bone and Joint Institute, Western University, London, Canada.
Disabil Rehabil. 2022 Jun;44(13):2958-2967. doi: 10.1080/09638288.2020.1851784. Epub 2020 Dec 8.
To identify, critically appraise, and synthesise the measurement properties of Patient-Specific Functional Scale (PSFS) in patients with upper extremity musculoskeletal disorders.
Medline, Embase, PubMed, and Google Scholar databases from January 1999 to November 2020 were searched. Prospective measurement studies that included patients with upper extremity musculoskeletal disorders, that reported on the psychometric properties of PSFS were included. We used the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) 2018 guideline for systematic reviews to appraise the studies.
Fourteen eligible studies were included. Three studies with adequate-very good quality and sufficient properties indicated excellent intra-class correlation coefficients (ICC) (≥0.75) in patients with shoulder pain (mean age 48 ± 11 years), multiple shoulder disorders (mean age 55 ± 16 years), and hand osteoarthritis (mean age 64 ± 9 years). The construct validity estimates of PSFS were moderate, when compared with Upper Extremity Functional Index (UEFI) ( = 0.50) and Numeric Pain Rating Scale (NPRS) ( = 0.51) in patients with combined upper extremity musculoskeletal disorders (shoulder/upper arm, wrist/hand and elbow/forearm).
The patient-specific functional scale can be considered as a reliable, valid, and responsive tool in assessing functional change in patients with shoulder disorders/pain.Implications for rehabilitationThe Patient-Specific Functional Scale (PSFS) can be considered as: • a reliable outcome measure in assessing functional change in patients with shoulder pain and hand osteoarthritis; • a valid measure in assessing functional limitation in patients with upper extremity disorders; • a measure that is sensitive to change (displays longitudinal validity) in assessing functional change in patients with upper extremity disorders and in patients with shoulder pain; and • a responsive outcome measure in assessing functional change in patients with upper extremity disorders.
识别、批判性评价和综合上肢运动系统疾病患者使用个体特定功能量表(PSFS)的测量属性。
从 1999 年 1 月至 2020 年 11 月,检索了 Medline、Embase、PubMed 和 Google Scholar 数据库。纳入了包含上肢运动系统疾病患者的前瞻性测量研究,且报告了 PSFS 心理测量特性的研究。我们使用 2018 年共识基础的健康测量仪器选择标准(COSMIN)系统评价指南来评价这些研究。
纳入了 14 项符合条件的研究。3 项研究质量为良好-非常好,且具有足够的特性,表明在患有肩痛(平均年龄 48±11 岁)、多种肩部疾病(平均年龄 55±16 岁)和手部骨关节炎(平均年龄 64±9 岁)的患者中,内部一致性系数(ICC)较高(≥0.75)。与上肢功能指数(UEFI)( = 0.50)和数字疼痛评分量表(NPRS)( = 0.51)相比,PSFS 的结构有效性估计值在患有上肢运动系统疾病(肩部/上臂、手腕/手部和肘部/前臂)的患者中为中等。
PSFS 可作为一种可靠、有效、灵敏的工具,用于评估肩部疾病/疼痛患者的功能变化。
PSFS 可作为:
评估肩痛和手部骨关节炎患者功能变化的可靠的结果测量工具;
评估上肢疾病患者功能受限的有效测量工具;
评估上肢疾病和肩部疼痛患者功能变化的敏感(显示纵向有效性)测量工具;
评估上肢疾病患者功能变化的敏感(反应性)结果测量工具。